23,24-Dihydrocucurbitacin B promotes lipid clearance by dual transcriptional regulation of LDLR and PCSK9
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
23,24-Dihydrocucurbitacin B promotes lipid clearance by dual transcriptional regulation of LDLR and PCSK9
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-29
DOI
10.1038/s41401-019-0274-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality
- (2016) Rishi K. Wadhera et al. Journal of Clinical Lipidology
- High-fructose feeding promotes accelerated degradation of hepatic LDL receptor and hypercholesterolemia in hamsters via elevated circulating PCSK9 levels
- (2015) Bin Dong et al. ATHEROSCLEROSIS
- Experimental design and analysis and their reporting: new guidance for publication in BJP
- (2015) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
- (2015) Joseph L. Goldstein et al. CELL
- PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- World Medical Association Declaration of Helsinki
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report
- (2013) Scott M. Grundy et al. Journal of Clinical Lipidology
- Synthesis and cytotoxic activity evaluation of dihydrocucurbitacin B and cucurbitacin B derivatives
- (2012) Karen Luise Lang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes
- (2012) Liwen Zhang et al. International Journal of Biological Sciences
- Animal welfare and the 3Rs in European biomedical research
- (2011) Dominic J. Wells Annals of the New York Academy of Sciences
- LRP6 Protein Regulates Low Density Lipoprotein (LDL) Receptor-mediated LDL Uptake
- (2011) Zhi-jia Ye et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PCSK9 LNA Antisense Oligonucleotides Induce Sustained Reduction of LDL Cholesterol in Nonhuman Primates
- (2011) Marie W Lindholm et al. MOLECULAR THERAPY
- Evaluation of the antitumoral effect of dihydrocucurbitacin-B in both in vitro and in vivo models
- (2009) Jarbas Mota Siqueira et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hepatocyte Nuclear Factor 1α Plays a Critical Role inPCSK9Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
- (2009) Hai Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antagonism of Secreted PCSK9 Increases Low Density Lipoprotein Receptor Expression in HepG2 Cells
- (2009) Markey C. McNutt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice
- (2008) Yi Luo et al. JOURNAL OF LIPID RESEARCH
- Octanorcucurbitane and Cucurbitane Triterpenoids from the Tubers ofHemsleya endecaphyllawith HIV-1 Inhibitory Activity
- (2007) Jian-Chao Chen et al. JOURNAL OF NATURAL PRODUCTS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now